DELIVER Commentary - Clyde Yancy, MD, FAHA

Rate:
5
added:
4 years ago
views:
2494
specialty:
Cardiology

Case description

Clyde Yancy, MD, FAHA, past president of the American Heart Association comments on the results of DELIVER, which found that among individuals with heart failure and a mildly reduced or preserved ejection fraction, dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death.

related terms: deliver trial, dapagliflozin


Natalia D
Editor

Natalia D

MD

This user also sharing

Recommended

show more